We are using our powerful mammalian cell-based Microcycle® discovery platform to build a pipeline of innovative cyclic peptide and small molecule drugs addressing intracellular targets, with a focus on cancer, immunology and inflammation.
Vision
Our goal and passion is to transform the lives of patients by developing innovative and better ways to treat challenging diseases
Science
Our revolutionary gene-encoded Microcycle® platform can unlock the therapeutic potential of intracellular targets by discovering biologically active cyclic peptides and small molecules through functional screening in the real world setting of a live mammalian cell.
Pipeline
We are deploying our platform to build a pipeline of innovative cyclic peptide and small molecule drugs that address high priority intracellular disease targets with a focus on cancer, immunology and inflammation.
